No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers

被引:0
作者
Malene Hove-Skovsgaard
Julie Abildgaard
Marco Gelpi
Julie Christine Gaardbo
Lilian Kolte
Henrik Ullum
Marius Trøseid
Birgitte Lindegaard
Susanne Dam Nielsen
机构
[1] Copenhagen University Hospital,Department of Infectious Diseases, Rigshospitalet
[2] University of Copenhagen,The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet
[3] University of Copenhagen,Department of Infectious Diseases, Hvidovre Hospital
[4] University of Copenhagen,Department of Pulmonary
[5] Copenhagen University Hospital, and Infectious Diseases, Nordsjællands Hospital
[6] Oslo University Hospital,Department of Clinical Immunology, Rigshospitalet
[7] Oslo University Hospital,Section of Clinical Immunology and Infectious Diseases
[8] Institute for Clinical Medicine,Research Institute of Internal Medicine
[9] University of Oslo,undefined
来源
BMC Infectious Diseases | / 20卷
关键词
HIV infection; Diabetes mellitus type 2; Fat distribution; Adiponectin; IL-6; sCD14;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 193 条
[1]  
Legarth RA(2010)Causes of death in HIV-1–infected patients treated with antiretroviral therapy, 1996–2006: collaborative analysis of 13 HIV cohort studies Clin Infect Dis 50 1387-1396
[2]  
Ahlström MG(2016)Long-term mortality in HIV-infected individuals 50 years or older: a Nationwide, population-based cohort study Jaids 71 213-218
[3]  
Kronborg G(2013)HIV infection and the risk of acute myocardial infarction JAMA Intern Med 173 614-622
[4]  
Larsen CS(2012)Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis HIV Med 13 453-468
[5]  
Pedersen C(2019)Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors AIDS. 33 675-683
[6]  
Pedersen G(2014)Obesity trends and body mass index changes after starting antiretroviral treatment: the Swiss HIV cohort study Open forum Infect Dis 1 ofu040-236
[7]  
Freiberg MS(2016)Weight gain and incident diabetes among HIV infected-veterans initiating antiretroviral therapy compared to uninfected individuals JAIDS J Acquir Immune Defic Syndr 73 228-188
[8]  
Chang C-CH(2015)Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:a: D study HIV Med 17 255-909
[9]  
Kuller LH(2014)Adipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome BMC Infect Dis 14 347-539
[10]  
Skanderson M(2009)Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis JAMA. 302 179-471